Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery

Biomaterials

Volumn 32, Issue 22, 2011, Pages 5213-5222

  Nam, Hye Yeong ^a   Kim, Jaesung ^a   Kim, Soojin ^b   Yockman, James W ^a   Kim, Sung Wan ^a   Bull, David A ^c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis; Bioreducible polymer; Cardiomyocyte; CPP; PCM

Indexed keywords

APOPTOSIS; BIOREDUCIBLE POLYMER; CARDIOMYOCYTE; CPP; PCM;

CELL DEATH; PEPTIDES; POLYMERS;

CONJUGATED POLYMERS;

CELL PENETRATING PEPTIDE; CYSTAMINE BISACRYLAMIDE DIAMINOHEXANE; FAS ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; POLYMER; PROTEIN TYROSINE PHOSPHATASE SHP 1; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIODEGRADABILITY; CELL HYPOXIA; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; GENETIC TRANSFECTION; HEART MUSCLE CELL; INCIDENCE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA INTERFERENCE; TARGET CELL;

ACRYLAMIDES; ANIMALS; APOPTOSIS; CELL-PENETRATING PEPTIDES; CYSTAMINE; GENE SILENCING; HEXANES; MATERIALS TESTING; MICE; MOLECULAR STRUCTURE; MYOCYTES, CARDIAC; NIH 3T3 CELLS; POLYMERS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RATS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

RATTUS;

EID: 79956104650     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.058     Document Type: Article

References (32)

1. Kim S.H., Jeong J.H., Ou M., Yockman J.W., Kim S.W., Bull D.A. Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. Biomaterials 2008, 29:4439-4446.
2. Hammond S.M., Caudy A.A., Hannon G.J. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2001, 2:110-119.
3. McManus M.T., Sharp P.A. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002, 3:737-747.
4. Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol 2006, 124:12-25.
5. Hammond S.M., Bernstein E., Beach D., Hannon G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in drosophila cells. Nature 2000, 404:293-296.
6. Nam H.Y., McGinn A., Kim P.H., Kim S.W., Bull D.A. Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials 2010, 31:8081-8087.
7. Ko Y.T., Hartner W.C., Kale A., Torchilin V.P. Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide. Gene Ther 2008, 16:52-59.
8. Torchilin V.P., Levchenko T.S., Rammohan R., Volodina N., Papahadjopoulos-Sternberg B., D'Souza G.G. Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc Natl Acad Sci U S A 2003, 100:1972-1977.
9. Tunnemann G., Karczewski P., Haase H., Cardoso M.C., Morano I. Modulation of muscle contraction by a cell-permeable peptide. J Mol Med 2007, 85:1405-1412.
10. Wei B., Wei Y., Zhang K., Wang J., Xu R., Zhan S., et al. Development of an antisense RNA delivery system using conjugates of the MS2 bacteriophage capsids and HIV-1 TAT cell penetrating peptide. Biomed Pharmacother 2009, 63:313-318.
11. Endoh T., Ohtsuki T. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. Adv Drug Deliv Rev 2009, 61:704-709.
12. Lundberg P., Langel Ü A brief introduction to cell-penetrating peptides. J Mol Recognit 2003, 16:227-233.
13. Meade B.R., Dowdy S.F. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv Drug Deliv Rev 2007, 59:134-140.
14. Bryant D., Becker L., Richardson J., Shelton J., Franco F., Peshock R., et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998, 97:1375-1381.
15. Song W., Lu X., Feng Q. Tumor necrosis factor-alpha induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc Res 2000, 45:595-602.
16. Stephanou A., Scarabelli T.M., Brar B.K., Nakanishi Y., Matsumura M., Knight R.A., et al. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 2001, 276:28340-28347.
17. Sugano M., Tsuchida K., Hata T., Makino N. RNA interference targeting SHP-1 attenuates myocardial infarction in rats. FASEB J 2005, 19:2054-2056.
18. Yamaoka M., Yamaguchi S., Suzuki T., Okuyama M., Nitobe J., Nakamura N., et al. Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J Mol Cell Cardiol 2000, 32:881-889.
19. Granata R., Trovato L., Gallo M.P., Destefanis S., Settanni F., Scarlatti F., et al. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc Res 2009, 83:303-312.
20. Kim T.I., Ou M., Lee M., Kim S.W. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 2009, 30:658-664.
21. Ou M., Wang X.L., Xu R., Chang C.W., Bull D.A., Kim S.W. Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity. Bioconjug Chem 2008, 19:626-633.
22. Brumbach J.H., Lin C., Yockman J., Kim W.J., Blevins K.S., Engbersen J.F.J., et al. Mixtures of poly(triethylenetetramine/cystamine bisacrylamide) and poly(triethylenetetramine/cystamine bisacrylamide)-g-poly(ethylene glycol) for improved gene delivery. Bioconjug Chem 2010, 21:1753-1761.
23. Christensen L.V., Chang C.-W., Kim W.J., Kim S.W., Zhong Z., Lin C., et al. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem 2006, 17:1233-1240.
24. Kajstura J., Cheng W., Reiss K., Clark W.A., Sonnenblick E.H., Krajewski S., et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996, 74:86-107.
25. Lee P., Sata M., Lefer D.J., Factor S.M., Walsh K., Kitsis R.N. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 2003, 284:H456-H463.
26. Nabel E.G. Cardiovascular disease. N Engl J Med 2003, 349:60-72.
27. Chen H.E., Chang S., Trub T., Neel B.G. Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol 1996, 16:3685-3697.
28. Daigle I., Yousefi S., Colonna M., Green D.R., Simon H.U. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med 2002, 8:61-67.
29. Mizuno K., Tagawa Y., Mitomo K., Watanabe N., Katagiri T., Ogimoto M., et al. Src homology region 2 domain-containing phosphatase 1 p.sitively regulates B cell receptor-induced apoptosis by modulating association of B cell linker protein with Nck and activation of c-Jun NH2-terminal kinase. J Immunol 2002, 169:778-786.
30. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001, 104:330-335.
31. Kariko K., Bhuyan P., Capodici J., Weissman D. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J Immunol 2004, 172:6545-6549.
32. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005, 11:263-270.